Document Detail

Hodgkin lymphoma.
MedLine Citation:
PMID:  23023715     Owner:  NLM     Status:  MEDLINE    
Hodgkin lymphoma (HL), a B cell-derived cancer, is one of the most common lymphomas. In HL, the tumor cells--Hodgkin and Reed-Sternberg (HRS) cells--are usually very rare in the tissue. Although HRS cells are derived from mature B cells, they have largely lost their B cell phenotype and show a very unusual co-expression of markers of various hematopoietic cell types. HRS cells show deregulated activation of multiple signaling pathways and transcription factors. The activation of these pathways and factors is partly mediated through interactions of HRS cells with various other types of cells in the microenvironment, but also through genetic lesions. The transforming events involved in the pathogenesis of HL are only partly understood, but mutations affecting the NF-κB and JAK/STAT pathways are frequent. The dependency of HRS cells on microenvironmental interactions and deregulated signaling pathways may offer novel strategies for targeted therapies.
Ralf Küppers; Andreas Engert; Martin-Leo Hansmann
Related Documents :
24715465 - Pulses of notch activation synchronise oscillating somite cells and entrain the zebrafi...
23719745 - Adipose derived mesenchymal stem cells partially rescue mitomycin c treated arpe19 cell...
24629595 - Development rate and gene expression of ivp bovine embryos cocultured with bovine ovidu...
23367365 - A new microfluidic device for electric lysis and separation of cells.
3296895 - Interactions between alveolar macrophages, monocytes, and granulocytes. implications fo...
20816975 - Ecdysone signaling and transcript signature in drosophila cells resistant against metho...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review     Date:  2012-10-01
Journal Detail:
Title:  The Journal of clinical investigation     Volume:  122     ISSN:  1558-8238     ISO Abbreviation:  J. Clin. Invest.     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-01     Completed Date:  2013-02-01     Revised Date:  2013-07-11    
Medline Journal Info:
Nlm Unique ID:  7802877     Medline TA:  J Clin Invest     Country:  United States    
Other Details:
Languages:  eng     Pagination:  3439-47     Citation Subset:  AIM; IM    
Institute of Cell Biology (Cancer Research), Medical School, University of Duisburg-Essen, Essen, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antigens, Differentiation, B-Lymphocyte / analysis
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
B-Lymphocytes / pathology
Cell Lineage
Cell Transformation, Neoplastic / genetics
Clinical Trials as Topic
Epstein-Barr Virus Infections / pathology
Gene Expression Regulation, Neoplastic
Germ-Line Mutation
Herpesvirus 4, Human / genetics,  pathogenicity
Hodgkin Disease* / classification,  etiology,  genetics,  pathology,  therapy,  virology
Molecular Targeted Therapy
NF-kappa B / metabolism
Neoplasm Proteins / biosynthesis,  genetics,  physiology
Reed-Sternberg Cells / immunology,  pathology
Signal Transduction / genetics,  physiology
Transcription Factors / genetics,  physiology
Tumor Microenvironment
Tumor Virus Infections / pathology
Reg. No./Substance:
0/Antigens, Differentiation, B-Lymphocyte; 0/NF-kappa B; 0/Neoplasm Proteins; 0/Transcription Factors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Molecular pathogenesis of chronic lymphocytic leukemia.
Next Document:  New molecular insights into peripheral T cell lymphomas.